JSM 2017 Online Program

Legend:
CC = Baltimore Convention Center, H = Hilton Baltimore
* = applied session ! = JSM meeting theme

Keyword Search Criteria: Phase 2 returned 4 record(s)

Sunday, 07/30/2017

Design of Dose Finding Studies Under MCP-Mod
Jose Pinheiro, Johnson & Johnson
5:25 PM

Tuesday, 08/01/2017

Determination of Interim Go/No-Go Criteria with Simulations of Longitudinal Continuous Data in a Phase 2 Clinical Trial of a Neurodegenerative Disorder
Weining Z Robieson, AbbVie Inc.; Greg Cicconetti, Abbvie; Deli Wang, AbbVie, Inc.
11:05 AM

Wednesday, 08/02/2017

Real World Evidence to Support Accelerated Approval Processes
Sebastian Schneeweiss, Harvard Medical School; Jessica Franklin, Harvard Medical School
8:35 AM

Thursday, 08/03/2017

Dose Selection in Phase 2 Studies for a Drug Combination Using a Response Surface Modeling Technique
Hongtao Zhang, AbbVie Inc.; Jingjing Gao, AbbVie Inc.; Qiming Liao, AbbVie Inc.; Alan Hartford, AbbVie; Jyotirmoy Dey, AbbVie Inc.
8:35 AM